APM
IMCR icon

Avidity Partners Management’s Immunocore IMCR Stock Holding History

Avidity Partners Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200,000
Closed -$6.23M – 73
2024
Q3 		$6.23M Hold
200,000
– – 0.32% 64
2024
Q2 		$6.78M Sell
200,000
-86,400
-30% -$4.41M 0.29% 67
2024
Q1 		$18.6M Sell
286,400
-13,800
-5% -$947K 0.6% 52
2023
Q4 		$20.5M Sell
300,200
-48,000
-14% -$2.49M 0.75% 49
2023
Q3 		$18.1M Sell
348,200
-226,800
-39% -$13.4M 0.73% 52
2023
Q2 		$34.5M Sell
575,000
-194,800
-25% -$11.1M 1.2% 36
2023
Q1 		$38.1M Sell
769,800
-384,200
-33% -$21.6M 1.26% 31
2022
Q4 		$65.9M Sell
1,154,000
-925,100
-44% -$52.1M 1.43% 25
2022
Q3 		$97.6M Buy
2,079,100
+729,100
+54% +$34.7M 1.98% 17
2022
Q2 		$50.4M Sell
1,350,000
-13,800
-1% -$448K 1.16% 28
2022
Q1 		$40.8M Buy
1,363,800
+133,800
+11% +$3.38M 0.85% 34
2021
Q4 		$42.1M Buy
1,230,000
+134,400
+12% +$4.87M 0.89% 38
2021
Q3 		$40.6M Buy
1,095,600
+494,600
+82% +$16.7M 0.9% 38
2021
Q2 		$23.5M Buy
601,000
+51,000
+9% +$1.97M 0.63% 47
2021
Q1 		$23.4M Buy
+550,000
New +$24.5M 0.65% 52

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Avidity Partners Management's IMCR Position: Q4 2024 in Review

Avidity Partners Management sold out of Immunocore (IMCR) in Q4 2024, closing a stake of 200,000 shares — an estimated $6.23M sold.

Avidity Partners Management first reported a position in IMCR in Q1 2021 and held it in 15 quarters. The position peaked at $97.6M in Q3 2022. 115 funds tracked by Wall St. Rank hold IMCR as of Q4 2024.

  • Avidity Partners Management reported no remaining Immunocore position as of Q4 2024 after selling out during the quarter.
  • Avidity Partners Management sold 200,000 Immunocore shares in Q4 2024, an estimated $6.23M.
  • Avidity Partners Management first reported a position in Immunocore in Q1 2021 and held it in 15 quarters.
  • Avidity Partners Management's Immunocore position peaked at $97.6M in Q3 2022.
  • 115 funds tracked by Wall St. Rank held Immunocore as of Q4 2024.

Based on Avidity Partners Management's 13F filing for Q4 2024, filed 14 Feb 2025.